A PHASE III INVESTIGATOR-INITIATED CLINICAL TRIAL COMPARING REMIMAZOLAM WITH PLACEBO FOR SADATION IN JAPANESE PATIENTS UNDERGOING UPPER GASTROINTESTINAL ENDOSCOPY

Mitsuru Esaki  ^{1, 2}     Ryoji Ichijima  ^{3, 4}     Hisatomo Ikehara  ^{4, 5}     Daisuke Yamaguchi  ⁶     Yasuhiko Nagata  ⁷     Kanako Ogura  ^{4, 7}     Yosuke Minoda  ⁷     Hiroyuki Ono  ⁸     Yuki Maeda  ⁸     Shinsuke Kiriyama  ⁸     Unknown Unknown  ⁹     Yuichi Kanmura  ¹⁰     Takuji Gotoda  ^10    
1 Harasanshin Hospital, Fukuoka, Japan
² Kyushu University, Fukuoka, Japan
³ Kiriyama Clinic, Takasaki, Japan
⁴ Nihon University School of Medicine, Tokyo, Japan
⁵ Kitasato University School of Medicine, Sagamihara, Japan
⁶ National Hospital Organization Ureshino Medical Center, Ureshino, Japan
⁷ Nagata Surgery and Gastroenterological Clinic, Nishitokyo-shi, Japan
⁸ Shizuoka Cancer Center, Shizuoka, Japan
⁹ Tonan Hospital, Hokkaido, Japan
¹⁰ Fujimoto General Hospital, Miyazaki, Japan

Topic
Oesophagus

Session
PP 01 Oesophageal, gastric and duodenal disorders (Posters)

Conference
UEG Week 2023

Citation
United European Gastroenterology Journal 2023; 11 (Supplement 8)